Oxford Ebola vaccine enters human trials in UK eight weeks after outbreak declared emergency

The UK has begun the first clinical trial of an experimental Ebola vaccine developed by scientists at the University of Oxford in just eight weeks, following a public health emergency declaration on 17 May. According to BBC News, the UK medicines regulator approved the trial, making it the first of four vaccines under development to enter human testing. Healthy adult volunteers are now being recruited for the study.

BBC NewsUK begins trials of Ebola vaccine developed in just eight weeks

"A new vaccine to combat a strain of Ebola spreading across the Democratic Republic of Congo (DRC) will soon be tested on adults in the UK."

Sky NewsHuman trials of new Ebola vaccine set to begin in UK

Sky News reported that the vaccine targets the strain currently spreading in the DRC, where the outbreak has escalated into a public health emergency. The rapid development timeline reflects an urgent global push to contain the virus.

"The UK medicines regulator has given approval for an experimental vaccine to be tested on healthy adults."

BBC News confirmed that the regulator's green light allowed Oxford researchers to proceed with human trials. Gamereactor noted that the outbreak was declared a public health emergency on 17 May, prompting countries including the UK to ramp up efforts, with Oxford beginning work immediately.

GamereactorEbola vaccine human trials will soon begin in the UK

Theukpulse.co.uk highlighted that the UK is launching clinical trials for a rapidly developed Ebola vaccine, underscoring the speed of the scientific response. The trial marks a critical step toward controlling future outbreaks, with the Oxford vaccine being the first of four candidates to reach the clinical stage in the UK."

theukpulse.co.ukUK Launches Clinical Trials for Rapidly Developed Ebola Vaccine